Virtu Financial’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Virtu Financial’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,445	Closed	-$30K	–	2092
2024 Q1	$30K	Buy	+11,445	New	+$28.3K	﹤0.01%	1110
2023 Q3	–	Sell	-20,585	Closed	-$62K	–	2100
2023 Q2	$62K	Buy	+20,585	New	+$79.4K	﹤0.01%	1115

Virtu Financial's KNTE Position: Q2 2024 in Review

Virtu Financial sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 11,445 shares — an estimated $30K sold.

Virtu Financial first reported a position in KNTE in Q2 2023 and held it in 2 quarters. The position peaked at $62K in Q2 2023. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Virtu Financial reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 11,445 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $30K.
Virtu Financial first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Virtu Financial's Kinnate Biopharma Inc. Common Stock position peaked at $62K in Q2 2023.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.